Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Nuheara Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Nuheara şirketinin kazançları yıllık ortalama -11.8% oranında azalırken, Tech sektörünün kazançları yıllık 13.2% oranında artan oldu. Gelirler yıllık ortalama 4.3% oranında artan oldu.

Anahtar bilgiler

-11.8%

Kazanç büyüme oranı

13.0%

EPS büyüme oranı

Tech Sektör Büyümesi	11.8%
Gelir büyüme oranı	4.3%
Özkaynak getirisi	-246.9%
Net Marj	-653.3%
Son Kazanç Güncellemesi	30 Jun 2023

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Nuheara nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

ASX:NUH Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri	Ar-Ge Giderleri
30 Jun 23	2	-13	7	4
31 Mar 23	2	-13	8	5
31 Dec 22	2	-14	8	6
30 Sep 22	3	-14	10	6
30 Jun 22	4	-15	11	6
31 Mar 22	5	-15	11	7
31 Dec 21	7	-14	11	7
30 Sep 21	9	-11	11	7
30 Jun 21	11	-8	10	6
31 Mar 21	9	-7	11	3
31 Dec 20	7	-7	11	2
30 Sep 20	5	-9	11	3
30 Jun 20	2	-12	11	3
31 Mar 20	2	-12	11	3
31 Dec 19	2	-12	11	3
30 Sep 19	2	-11	11	2
30 Jun 19	2	-10	11	2
31 Mar 19	3	-9	11	1
31 Dec 18	3	-7	10	0
30 Sep 18	4	-7	9	0
30 Jun 18	4	-7	9	0
31 Mar 18	4	-7	8	0
31 Dec 17	4	-7	7	1
30 Sep 17	3	-6	6	0
30 Jun 17	2	-5	4	0
31 Dec 16	0	-8	2	1
30 Sep 16	0	-8	2	1
30 Jun 16	0	-7	1	1

Kaliteli Kazançlar: NUH şu anda kârlı değil.

Büyüyen Kar Marjı: NUH şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NUH kârlı değildir ve zararlar son 5 yılda yılda 11.8% oranında artmıştır.

Büyüme Hızlandırma: NUH 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: NUH kârlı olmadığından, geçmiş yıl kazanç büyümesinin Tech sektörüyle ( 12.1% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: NUH hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -246.93% ) sahiptir.

Nuheara Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Recent updates

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 1.850332 million.

Nuheara Limited Announces the Retirement of David Cannington as Non-Executive Director

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.929624 million.

New major risk - Shareholder dilution

Does Nuheara (ASX:NUH) Have A Healthy Balance Sheet?

Full year 2023 earnings released: AU$0.084 loss per share (vs AU$0.16 loss in FY 2022)

Nuheara Limited, Annual General Meeting, Nov 22, 2023

New major risk - Financial position

Nuheara Limited Announces Appointment of Catherine Morgan as Head of Compliance, Regulatory and Legal

New minor risk - Share price stability

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 4.4 million.

First half 2023 earnings released: AU$0.048 loss per share (vs AU$0.065 loss in 1H 2022)

Insufficient new directors

Nuheara Announces Commercial Availability of HP Hearing PRO OTC Hearing Aid

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 3.025401 million.

Nuheara Limited Receives US FDA Approval and Launches HP Hearing PRO

Nuheara Limited to Report Q1, 2023 Results on Oct 31, 2022

Nuheara Limited Announces the Resignation of Jean-Marie Rudd as CFO

Full year 2022 earnings released: AU$0.16 loss per share (vs AU$0.10 loss in FY 2021)

Nuheara Limited, Annual General Meeting, Nov 29, 2022

Full year 2022 earnings released: AU$0.15 loss per share (vs AU$0.093 loss in FY 2021)

Nuheara Limited Welcomes US Food and Drug Administration's Final Ruling, Establishing A Regulatory Category for Over-The-Counter (Otc) Hearing Aids in the United States

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Limited Announces Executive Changes

Nuheara Limited has filed an IPO in the amount of AUD 5 million.

Here's Why Nuheara (ASX:NUH) Must Use Its Cash Wisely

Nuheara Submits 510(k) for U.S. FDA Clearance

Nuheara Announces Executive Changes

Nuheara Limited Announces Successful Clinical Trial Self-Fitted Hearing Aids

Nuheara Limited to Report Q2, 2022 Results on Jan 31, 2022

Nuheara Clinical Trial and FDA 510(K) Pathway Update

We Think Nuheara (ASX:NUH) Needs To Drive Business Growth Carefully

Nuheara Limited Provides Update on Clinical Trial and Pathway to FDA 510(K) Approval

Is Nuheara (ASX:NUH) In A Good Position To Deliver On Growth Plans?

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.011 loss in FY 2020)

Nuheara Limited Receives U.S. FDA Registration and Hearing Aid Device Listing

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in 1H 2020)

What Can We Make Of Nuheara's (ASX:NUH) CEO Compensation?

Nuheara Limited has completed a Follow-on Equity Offering in the amount of AUD 11.5 million.

Nuheara Limited announced that it expects to receive AUD 11.5 million in funding

Nuheara Limited Appoints Warwick Sauer as Director

Is Nuheara (ASX:NUH) Using Debt In A Risky Way?

Nuheara Receives $2 Million Phase II Works with HP Inc

Full year earnings released - AU$0.011 loss per share

Nuheara Limited announced that it has received funding

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin